Welcome to PsychU!

Virtual Event – Current Guidelines & Unmet Needs In The Treatment Of Agitation Associated With Alzheimer’s Dementia

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Virtual Event – Current Guidelines & Unmet Needs In The Treatment Of Agitation Associated With Alzheimer’s Dementia

This is a Virtual Event for PsychU members in Indiana, Kentucky, and Ohio.

Individualized and multimodal treatment plans are recommended for patients with Alzheimer’s disease and Agitation associated with Alzheimer’s Dementia (AAD). There is a need for better identification of AAD. There is also a need for approved pharmacological treatments that have proven and favorable benefit, risk profiles to reduce symptoms and ultimately improve burden to caregivers and healthcare.

In this discussion, current treatment guidelines, assess risk/benefit profile, and discuss unmet needs of AAD treatment will be reviewed.

Featuring

Elizabeth-DiNapoli

Elizabeth DiNapoli, PhD (OPDC)

Senior Medical Science Liaison

More
Dr. DiNapoli earned her PhD from the University of Alabama.
Alex-Matushek

Alex Matushek, PharmD, MBA (OPDC)

Medical Science Liaison

Speakers Elizabeth DiNapoli, PhD and Alex Matushek, PharmD, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Join PsychU Today to receive a wide array of tools and benefits

  • Join our multidisciplinary community that is improving mental health care… together
  • Quickly learn more about the topics you're interested in
  • Access an award-winning library of on-demand mental health resources
  • Gain key insights from industry expert & thought leaders